Director, 23andMe Therapeutics, Cardiometabolic Disease Research @ (August 2021 - November 2023)
Sr. Principal Scientist @ (October 2019 - August 2021)
Principal Scientist @ (March 2008 - October 2019)
Sr Scientist @ (August 2004 - March 2008)
Scientist @ (January 2001 - January 2004)
Daniel Lin Education
Massachusetts Institute of Technology
Doctor of Philosophy (Ph.D.) (Biology)
University of California, Berkeley
Bachelor of Arts (B.A.) (Molecular and Cell Biology)
Daniel Lin Skills
Analytical Skills
Animal Models
Antibodies
Assay Development
Biology
Biomarkers
Biopharmaceuticals
Biotechnology
Business Alliances
Cardiometabolic Disorders
Cell Based Assays
Cell Biology
Chronic Kidney Disease
Clinical Trials
Communication
Creative Problem Solving
Drug Design
Drug Development
Drug Discovery
Due Diligence
GPCRs
Genetics
High Throughput Screening
Immunology
In Vitro
Ion Channels
Mentoring
Microsoft Office
Molecular Biology
Molecular Pharmacology
Monoclonal Antibodies
NASH - Nonalcoholic steatohepatitis
Organization Skills
Pancreatic Beta Cell
People Management
Peptides
Pharmaceutical Industry
Pharmacodynamics
Pharmacokinetics
Pharmacology
Problem Solving
Project Management
Scientific Communications
Small molecule drug discovery
Smartsheet
Strategic Planning
Team Leadership
Teamwork
Type 2 Diabetes
siRNA
Gut Peptides
Endocrinology
Software Development
Solver
Public Speaking
LIN
Integration
Data Analysis
Nonalcoholic Steatohepatitis
Nash
Daniel Lin Summary
Daniel Lin, based in South San Francisco, CA, US, is currently a Distinguished Scientist at Genentech. Daniel Lin brings experience from previous roles at insitro, 23andMe and Amgen. Daniel Lin holds a Doctor of Philosophy (Ph.D.) in Biology @ Massachusetts Institute of Technology. With a robust skill set that includes Analytical Skills, Animal Models, Antibodies, Assay Development, Biology and more. Daniel Lin has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Daniel Lin?
Find contact details for 700 million professionals.